Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FR104 in de Novo Renal Transplant Patients
NCT04837092Phase 2Completed
- Sponsor
- CHU de Nantes
- Start
- Jun 2021
- Primary completion
- Apr 2025
- Modality
- Antibody Fragments
- Countries
- 1
01
Overview
A Phase 2 trial of FR104 in kidney transplant rejection, sponsored by CHU de Nantes. Started Jun 2021; status: completed.
02
Drugs
FR104
03
Conditions
kidney transplant rejection
Beyond the preview
Go deeper on NCT04837092.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04837092.